CIK: 0001856083
Total reported value
$6.1B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 21.74% | -0.88% | — | |
| 2 | IMVT | Immunovant INC | Stock-Other | 5.22% | — | +18.48% | |
| 3 | GH | Guardant Health INC | Stock-Healthcare | 5.10% | -0.06% | -32.60% | |
| 4 | GPCR | Structure Therapeutics INC | Stock-Other | 5.10% | -1.73% | -2.47% | |
| 5 | TARS | Tarsus Pharmaceuticals INC | Stock-Other | 4.39% | — | +0.13% | |
| 6 | DVAX | Dynavax Technologies CORP | Stock-Other | 4.31% | -4.31% | EXIT | |
| 7 | CYTK | Cytokinetics INC | Stock-Healthcare | 3.78% | -2.30% | -22.40% | |
| 8 | AXSM | Axsome Therapeutics INC | Stock-Healthcare | 3.74% | -0.70% | +27.78% | |
| 9 | APLSUSD | Apellis Pharmaceuticals INC | Stock-Other | 3.47% | -0.49% | -3.13% | |
| 10 | PCVX | Vaxcyte INC | Stock-Other | 3.29% | +0.79% | +33.33% | |
| 11 | MAZE | Maze Therapeutics INC | Stock-Other | 3.14% | -1.44% | +7.53% | |
| 12 | VERA | Vera Therapeutics INC | Stock-Other | 2.55% | +0.15% | — | |
| 13 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 2.44% | -1.38% | +9153.30% | |
| 14 | IONS | Ionis Pharmaceuticals INC | Stock-Healthcare | 2.40% | -0.01% | -55.36% | |
| 15 | NRIX | Nurix Therapeutics INC | Stock-Other | 2.38% | -0.77% | +16.17% | |
| 16 | MBX | Mbx Biosciences INC | Stock-Other | 1.83% | -0.49% | +3.17% | |
| 17 | OCUL | Ocular Therapeutix INC | Stock-Other | 1.75% | +0.97% | -32.36% | |
| 18 | GRAL | Grail INC | Stock-Healthcare | 1.56% | — | — | |
| 19 | VRDN | Viridian Therapeutics INC | Stock-Other | 1.40% | -0.95% | -53.07% | |
| 20 | LBRX | Lb Pharmaceuticals INC | Stock-Other | 1.33% | — | — | |
| 21 | IMCR | Immunocore Holdings Plc-adr | Stock-Other | 1.24% | -0.29% | +11.33% | |
| 22 | ORKA | Oruka Therapeutics INC | Stock-Other | 1.17% | +0.46% | -18.58% | |
| 23 | BBIO | Bridgebio Pharma INC | Stock-Healthcare | 1.10% | — | -32.49% | |
| 24 | CRMD | Cormedix INC | Stock-Other | 1.09% | -0.39% | +954.82% | |
| 25 | MLTX | Moonlake Immunotherapeutics | Stock-Other | 1.08% | +0.87% | — | |
| 26 | ALKS | Alkermes plc | Stock-Healthcare | 1.00% | +1.07% | — | |
| 27 | DYN | Dyne Therapeutics INC | Stock-Other | 0.92% | -0.33% | +32.50% | |
| 28 | CLDX | Celldex Therapeutics INC | Stock-Other | 0.92% | -0.25% | -4.96% | |
| 29 | CMPS | Compass Pathways PLC | Stock-Other | 0.90% | +0.20% | -6.68% | |
| 30 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 0.89% | +1.16% | — | |
| 31 | SLNOEUR | Soleno Therapeutics INC | Stock-Other | 0.83% | -0.24% | — | |
| 32 | VSTM | Verastem INC | Stock-Other | 0.79% | -0.29% | — | |
| 33 | BCAX | Bicara Therapeutics INC | Stock-Other | 0.78% | +0.54% | +7.72% | |
| 34 | GERN | Geron CORP | Stock-Other | 0.77% | — | -20.89% | |
| 35 | ✓ | Engene Holdings INC | Stock-Other | 0.70% | — | +95.48% | |
| 36 | ANIP | Ani Pharmaceuticals INC | Stock-Other | 0.67% | — | +6.15% | |
| 37 | 430 | Terns Pharmaceuticals INC | Stock-Other | 0.55% | +0.37% | -89.74% | |
| 38 | ENTA | Enanta Pharmaceuticals INC | Stock-Other | 0.55% | — | — | |
| 39 | BRD1EUR | Mind Medicine Mindmed INC | Stock-Other | 0.40% | -0.40% | EXIT | |
| 40 | TNGX | Tango Therapeutics INC | Stock-Other | 0.39% | +0.55% | +68.75% | |
| 41 | XFOR | X4 Pharmaceuticals INC | Stock-Other | 0.36% | — | +346.66% | |
| 42 | ATAI | AtaiBeckley Inc. | Stock-Other | 0.34% | -0.34% | EXIT | |
| 43 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 0.29% | -0.29% | EXIT | |
| 44 | COGT | Cogent Biosciences INC | Stock-Other | 0.29% | +0.34% | — | |
| 45 | HELP | Cybin INC | Stock-Other | 0.27% | — | +85.43% | |
| 46 | CNTX | Context Therapeutics INC | Stock-Other | 0.19% | — | — | |
| 47 | MNPR | Monopar Therapeutics INC | Stock-Other | 0.11% | — | — | |
| 48 | BHVN | Biohaven Ltd. | Stock-Other | 0.10% | — | — | |
| 49 | ✓ | Crescent Biopharma INC. | Stock-Other | 0.10% | — | — | |
| 50 | ALGS | Aligos Therapeutics INC | Stock-Other | 0.07% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BMRN | Biomarin Pharmaceutical INC | +2.4% | +9153.30% | Add |
| 2 | GPCR | Structure Therapeutics INC | +1.8% | -2.47% | Trim |
| 3 | CRMD | Cormedix INC | +0.9% | +954.82% | Add |
| 4 | IMVT | Immunovant INC | +0.8% | +18.48% | Add |
| 5 | NRIX | Nurix Therapeutics INC | +0.8% | +16.17% | Add |
| 6 | AXSM | Axsome Therapeutics INC | +0.7% | +27.78% | Add |
| 7 | MBX | Mbx Biosciences INC | +0.3% | +3.17% | Add |
| 8 | MAZE | Maze Therapeutics INC | +0.3% | +7.53% | Add |
| 9 | PCVX | Vaxcyte INC | +0.3% | +33.33% | Add |
| 10 | ✓ | Engene Holdings INC | +0.3% | +95.48% | Add |
| 11 | XFOR | X4 Pharmaceuticals INC | +0.3% | +346.66% | Add |
| 12 | DYN | Dyne Therapeutics INC | +0.2% | +32.50% | Add |
| 13 | HELP | Cybin INC | +0.1% | +85.43% | Add |
| 14 | TNGX | Tango Therapeutics INC | +0.1% | +68.75% | Add |
| 15 | DVAX | Dynavax Technologies CORP | -0.1% | — | Unchanged |
| 16 | LBRX | Lb Pharmaceuticals INC | -0.2% | — | Unchanged |
| 17 | ORKA | Oruka Therapeutics INC | -0.3% | -18.58% | Trim |
| 18 | RAPT | Rapt Therapeutics INC | -0.5% | -85.30% | Trim |
| 19 | TARS | Tarsus Pharmaceuticals INC | -0.6% | +0.13% | Add |
| 20 | GERN | Geron CORP | -0.8% | -20.89% | Trim |
| 21 | 430 | Terns Pharmaceuticals INC | -1% | -89.74% | Trim |
| 22 | XENE | Xenon Pharmaceuticals INC | -1.1% | -69.46% | Trim |
| 23 | APLSUSD | Apellis Pharmaceuticals INC | -1.6% | -3.13% | Trim |
| 24 | VRDN | Viridian Therapeutics INC | -1.8% | -53.07% | Trim |
| 25 | OCUL | Ocular Therapeutix INC | -2.1% | -32.36% | Trim |
| 26 | GH | Guardant Health INC | -2.1% | -32.60% | Trim |
| 27 | CYTK | Cytokinetics INC | -2.8% | -22.40% | Trim |
| 28 | IONS | Ionis Pharmaceuticals INC | -4.6% | -55.36% | Trim |
| 29 | XBI | Ss Spdr S&p Biotech ETF | — | NEW | New buy |
| 30 | AKRO | Akero Therapeutics INC | — | EXIT | Sold out |
| 31 | VERA | Vera Therapeutics INC | — | NEW | New buy |
| 32 | ETNBGBP | 89bio INC | — | EXIT | Sold out |
| 33 | PTGX | Protagonist Therapeutics INC | — | EXIT | Sold out |
| 34 | GRAL | Grail INC | — | NEW | New buy |
| 35 | MLTX | Moonlake Immunotherapeutics | — | NEW | New buy |
| 36 | ALKS | Alkermes plc | — | NEW | New buy |
| 37 | EXK | Exact Sciences CORP | — | EXIT | Sold out |
| 38 | 260 | Centessa Pharmaceuticals-adr | — | NEW | New buy |
| 39 | SLNOEUR | Soleno Therapeutics INC | — | NEW | New buy |
| 40 | VSTM | Verastem INC | — | NEW | New buy |
| 41 | OLMA | Olema Pharmaceuticals INC | — | EXIT | Sold out |
| 42 | ENTA | Enanta Pharmaceuticals INC | — | NEW | New buy |
| 43 | CDTX | Cidara Therapeutics INC | — | EXIT | Sold out |
| 44 | QURE | uniQure N.V. | — | EXIT | Sold out |
| 45 | JBIO | Jade Biosciences INC | — | EXIT | Sold out |
| 46 | ATAI | AtaiBeckley Inc. | — | NEW | New buy |
| 47 | GHRS | GH Research PLC | — | EXIT | Sold out |
| 48 | COGT | Cogent Biosciences INC | — | NEW | New buy |
| 49 | GMAB | Genmab A/s -sp Adr | — | EXIT | Sold out |
| 50 | IMA | Imagenebio INC | — | EXIT | Sold out |